NHPEF yields 4.20% · JNJ yields 2.13%● Live data
📍 NHPEF pulled ahead of the other in Year 1
Combined, NHPEF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NHPEF + JNJ for your $10,000?
New Hope Corporation Limited explores for, develops, produces, and processes coal, and oil and gas properties. It operates through three segments: Coal Mining in Queensland, Coal Mining in New South Wales, and Other. The company holds interests in two open cut coal mines that produces thermal coal, which include the New Acland project located in Oakey, Queensland; and the Bengalla mine situated in the Hunter Valley region of New South Wales. It also holds 849 square kilometers of net oil-producing acreage in nine production projects located in the Cooper-Eromanga Basin. In addition, the company engages in the farming, grazing, and land management activities; and operation of bulk handling facility comprising receiving, storage, and shipping of coal, construction sand and aggregates, chips and pellets, and mineral sands, as well as raw and processed minerals, such as bauxite, manganese, diatomite, etc. Further, it is involved in port operation and handling; logistics; and marketing activities. The company has operations in Japan, China, Taiwan, Chile, Korea, Vietnam, India, Australia, and internationally. New Hope Corporation Limited was founded in 1952 and is headquartered in Brisbane, Australia.
Full NHPEF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.